MYLK and prostate carcinoma: Knockdown of circRNA-MYLK significantly inhibited cell viability, increased apoptotic cell number and decreased the number of invasive migratory prostate cancer cells; however, those effects were reversed in an up-regulated circRNA-MYLK setting.